It is with great sadness we learnt that Dr Rob Loblay MBBS PhD FRACP passed away in early October 2024. 

Dr Rob Loblay made significant contributions to ASCIA, particularly in the area of anaphylaxis management during his time as Chair of the ASCIA Anaphylaxis working party. This includes his key role in:

• Advocating for PBS reimbursement of adrenaline injector devices in Australia in 2003.
• Developing the first version of the ASCIA Action Plan for Anaphylaxis in 2003. 

It was inspiring and enjoyable to work with Dr Loblay on projects that have had such a positive long-term impact on allergic disease management. 

Dr Loblay was Director of the Allergy Unit at Royal Prince Alfred Hospital in Sydney.

On behalf of ASCIA, we send condolences to Rob Loblay's family, friends and colleagues on the loss of a visionary man and clinician, who will be missed but fondly remembered.

This news item was issued on 7 October 2024 by Jill Smith, CEO of ASCIA, the peak professional body for clinical immunology and allergy in Australia and New Zealand.